XSHE

002252

Market cap4.98bUSD

Oct 09, Last price

5.06CNY

0.00%

10.48%

Jan 2017

-78.09%

IPO

-18.78%

Name

Shanghai RAAS Blood Products Co Ltd

Chart & performance

D1W1MN

P/E

21.15

P/S

4.54

EPS

0.24

Div yield, %

0.65%

Shrs. gr., 5y

-0.51%

Rev. gr., 5y

21.62%

Revenues

7.35b

-10.13%

Net income

1.58b

-28.10%

CFO

-105m

L-78.24%

Dividend

Jun 24, 20260.033 CNY/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.

Key people

Lixia Tan

Chairman of the Board · since 2024

Jun Xu

Vice Chairman of the Board, General Manager · since 2024

Leqi Chen

Finance Director · since 2021

Qinbing Huang

Deputy General Manager · since 2024

Hui Lu

Deputy General Manager · since 2013

Jihui Shen

Deputy General Manager · since 2004

Zhengmin Song

Deputy General Manager · since 2020

Zheng Liu

Deputy General Manager, Secretary of the Board · since 2021

Ying Gong

Director · since 2024

Congqi Gu

Director · since 2024

Amarant Martinez Carrio

Director · since 2024

Quanli Wang

Director · since 2024

Xiangrui Bu